Balanced news tone
News Sentiment
AJANTPHARM sentiment intelligence
Ajanta Pharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
35 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
+0.7% over one week, +6.9% over four weeks, trend active, and materially above fair value.
Top 14 Pharma Stocks To Buy In India July 2026
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
0.7%
Price digesting
Trend fit
Trend active
6.9% over four weeks
Fair value
33.8%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
27
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Samco
Direct company coverage
Top 14 Pharma Stocks To Buy In India July 2026
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 06:50
- Source
- Samco
scanx.trade
Direct company coverage
Ravi Agrawal releases pledge on 2,600 Ajanta Pharma shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 05:20
- Source
- scanx.trade
The Malaysian Reserve
Direct company coverage
Five Trends That Will Shape the Future of Obesity Care in India: Ajanta Pharma Shares Its Perspective on the Next Decade of Metabolic Health
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 03:42
- Source
- The Malaysian Reserve
scanx.trade
Direct company coverage
Ajanta Pharma promoter releases pledge on 1.6 lakh shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Ajanta Pharma Annual Report FY 2025-26: Revenue ₹5,453 Crore, PAT ₹1,056 Crore
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 19 Jun 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Ajanta Pharma promoter pledges shares for new loan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- scanx.trade
HDFC Sky
Direct company coverage
Ajanta Pharma Shares Rise After ₹1,024 Cr Promoter Stake Sale
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 10 Jun 2026 07:00
- Source
- HDFC Sky
ETPharma.com
Direct company coverage
Ajanta Pharma promoter sells stake worth about $107 million
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 10 Jun 2026 07:00
- Source
- ETPharma.com
The Economic Times
Direct company coverage
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- The Economic Times
The Economic Times
Direct company coverage
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 07:00
- Source
- The Economic Times
scanx.trade
Direct company coverage
Ajanta Pharma promoter sells 2.76% stake via open market
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 07:00
- Source
- scanx.trade
The Economic Times
Direct company coverage
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- The Economic Times
simplywall.st
Direct company coverage
We Think That There Are Some Issues For Ajanta Pharma (NSE:AJANTPHARM) Beyond Its Promising Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- simplywall.st
IndiaMedToday
Direct company coverage
Ajanta Pharma Shares Gain As Q4 PAT Jumps 18% On Strong US Generics, Robust Revenue Growth
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- IndiaMedToday
Moneycontrol.com
Direct company coverage
Stocks to watch today: Coforge, L&T, M&M, KEC International, Ajanta Pharma in focus on May 6
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Moneycontrol.com
TipRanks
Direct company coverage
Ajanta Pharma Receives US FDA Form 483 With Five Observations at Paithan Plant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- TipRanks
CNBC TV18
Direct company coverage
Ajanta Pharma Ltd. Share Price Today - Ajanta Pharma Ltd. Stock Price Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- CNBC TV18
The Economic Times
Direct company coverage
Ajanta Pharma, Sun Pharma poised to tap GLP-1 opportunity amid market shift: Siddhartha Khemka
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Mar 2026 07:00
- Source
- The Economic Times
Moneycontrol.com
Direct company coverage
Restaurant Brands Asia shares fall 7% from day's high as Ajanta Pharma says report of buying stake as...
- Tone
- Negative 22/100
- Event
- Deals and strategy
- Published
- 20 Jan 2026 08:00
- Source
- Moneycontrol.com
simplywall.st
Direct company coverage
Are Robust Financials Driving The Recent Rally In Ajanta Pharma Limited's (NSE:AJANTPHARM) Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jan 2026 08:00
- Source
- simplywall.st
Business Standard
Direct company coverage
Ajanta Pharma hits over 5-month high after partnering with Biocon
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Dec 2025 08:00
- Source
- Business Standard
financialexpress.com
Direct company coverage
Ajanta Pharma ties up with Biocon to market semaglutide across 26 overseas markets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Dec 2025 08:00
- Source
- financialexpress.com
BusinessLine
Direct company coverage
Ajanta Pharma: Growth Continues But Valuations Drift Higher
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 29 Nov 2025 08:00
- Source
- BusinessLine
simplywall.st
Direct company coverage
Getting In Cheap On Ajanta Pharma Limited (NSE:AJANTPHARM) Is Unlikely
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Nov 2025 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Ajanta Pharma (NSE:AJANTPHARM) Has Announced A Dividend Of ₹28.00
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 06 Nov 2025 08:00
- Source
- simplywall.st
Business Standard
Direct company coverage
Ajanta Pharma offers growth potential amid US generic challenges: Nuvama
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Nov 2025 08:00
- Source
- Business Standard
HDFC Sky
Direct company coverage
Ajanta Pharma Q2 FY26 Profit Rises 20%, Declares ₹28 Interim Dividend per Share
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 03 Nov 2025 08:00
- Source
- HDFC Sky
simplywall.st
Direct company coverage
Ajanta Pharma Limited (NSE:AJANTPHARM) insiders have significant skin in the game with 42% ownership
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Sep 2025 07:00
- Source
- simplywall.st
TradingView
Direct company coverage
Ajanta Pharma shares rise 2.37% in early trade; stock among top gainers on Nifty Midcap 150
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2025 07:00
- Source
- TradingView
Value Research
Direct company coverage
Ajanta Pharma Ltd. Share Price Today | Ajanta Pharma Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Mar 2022 10:23
- Source
- Value Research